Director Fernando Aguirre receives 1,563 CVS Health (CVS) shares

Rhea-AI Filing Summary

AGUIRRE FERNANDO reported acquisition or exercise transactions in this Form 4 filing.

CVS Health Corp director Fernando Aguirre received a stock grant as part of his board compensation. On May 14, he was awarded 1,563 shares of CVS common stock at a reference price of $97.15 per share, issued in payment of a semi-annual retainer under the 2017 Incentive Compensation Plan. Following this award, he directly holds 42,513 CVS shares. This was a compensation-related grant, not an open-market purchase.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider AGUIRRE FERNANDO

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	1,563	$97.15	$152K

Holdings After Transaction: Common Stock — 42,513 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Shares granted: 1,563 shares Grant price per share: $97.15 per share Shares owned after grant: 42,513 shares +1 more

4 metrics

Shares granted 1,563 shares Common stock award to director Fernando Aguirre

Grant price per share $97.15 per share Market price used for semi-annual retainer payment

Shares owned after grant 42,513 shares Aguirre’s direct CVS common stock holdings post-transaction

Transaction date May 14, 2026 Date of reported stock grant

Key Terms

Common Stock, semi-annual retainer, 2017 Incentive Compensation Plan

3 terms

Common Stock financial

"Consists of common stock issued in payment of a semi-annual retainer"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

semi-annual retainer financial

"issued in payment of a semi-annual retainer, at the market price"

2017 Incentive Compensation Plan financial

"pursuant to the 2017 Incentive Compensation Plan"

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

AGUIRRE FERNANDO

(Last) (First) (Middle)

ONE CVS DRIVE

(Street)

WOONSOCKET RHODE ISLAND 02895

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CVS HEALTH Corp [ CVS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/14/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/14/2026		A(1)		1,563	A	$97.15	42,513	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan.

	/s/ Fernando Aguirre	05/15/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did CVS (CVS) director Fernando Aguirre report in this Form 4?

Fernando Aguirre reported receiving 1,563 shares of CVS common stock as a grant. The award was issued as payment of a semi-annual retainer at market price under the 2017 Incentive Compensation Plan, increasing his directly held shares to 42,513.

Was the CVS (CVS) insider transaction an open-market buy or a compensation grant?

The transaction was a compensation grant, not an open-market purchase. CVS issued 1,563 common shares to director Fernando Aguirre as payment of a semi-annual retainer, at market price, pursuant to the company’s 2017 Incentive Compensation Plan.

How many CVS (CVS) shares does Fernando Aguirre hold after this transaction?

After the grant, Fernando Aguirre directly holds 42,513 CVS common shares. This figure reflects his position following receipt of 1,563 shares issued as a semi-annual retainer under the CVS Health 2017 Incentive Compensation Plan.

What price was used for the CVS (CVS) director share grant reported in the Form 4?

The grant used a market price reference of $97.15 per share. CVS issued 1,563 common shares to director Fernando Aguirre at this price in payment of a semi-annual retainer under the 2017 Incentive Compensation Plan.

What plan governed the CVS (CVS) share grant to director Fernando Aguirre?

The share grant was made under the CVS Health 2017 Incentive Compensation Plan. According to the footnote, common stock was issued in payment of a semi-annual retainer at market price, resulting in a 1,563-share award to director Fernando Aguirre.